Description

Tune into PwC's Next in health for a discussion of lessons learned from deals in 2022 and what we can expect in 2023 and beyond. Topics include: 

•  Increase in M&A that’s more aligned to previous years 
•  Rethinking strategies and increasing innovation 
•  The important role of Private Equity  
•  Inflation Reduction Act implications

Speakers:
Nick Donkar, US Health Services Deals Sector Leader – Partner, PwC
Roel Van Den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC 
Host: Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.